Nomura Asset Management
IONS icon

Nomura Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Nomura Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4K Buy
+270
New +$20.3K ﹤0.01% 1291
2021
Q3 		– Sell
-7,417
Closed -$279K – 997
2021
Q2 		$296K Sell
7,417
-15,883
-68% -$622K ﹤0.01% 941
2021
Q1 		$1.05M Buy
23,300
+500
+2% +$27.9K 0.01% 827
2020
Q4 		$1.29M Buy
22,800
+200
+0.9% +$9.97K 0.01% 789
2020
Q3 		$1.07M Hold
22,600
– – 0.01% 767
2020
Q2 		$1.33M Hold
22,600
– – 0.01% 705
2020
Q1 		$1.07M Buy
22,600
+2,600
+13% +$145K 0.01% 680
2019
Q4 		$1.21M Hold
20,000
– – 0.01% 752
2019
Q3 		$1.2M Hold
20,000
– – 0.01% 737
2019
Q2 		$1.28M Buy
+20,000
New +$1.41M 0.01% 716
2016
Q3 		– Sell
-13,420
Closed -$313K – 998
2016
Q2 		$313K Hold
13,420
– – 0.01% 836
2016
Q1 		$544K Buy
13,420
+1,200
+10% +$48.7K 0.01% 782
2015
Q4 		$757K Hold
12,220
– – 0.01% 700
2015
Q3 		$494K Sell
12,220
-9,000
-42% -$466K 0.01% 794
2015
Q2 		$1.22M Sell
21,220
-5,000
-19% -$318K 0.02% 536
2015
Q1 		$1.67M Buy
26,220
+8,720
+50% +$592K 0.03% 442
2014
Q4 		$1.08M Hold
17,500
– – 0.02% 575
2014
Q3 		$680K Buy
17,500
+2,500
+17% +$88.6K 0.01% 697
2014
Q2 		$517K Hold
15,000
– – 0.01% 758
2014
Q1 		$648K Hold
15,000
– – 0.01% 715
2013
Q4 		$598K Sell
15,000
-5,000
-25% -$178K 0.01% 726
2013
Q3 		$751K Sell
20,000
-5,000
-20% -$149K 0.01% 644
2013
Q2 		$672K Buy
+25,000
New +$532K 0.01% 652

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Nomura Asset Management's IONS Position: Q2 2026 in Review

Nomura Asset Management opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 270 shares worth $21.4K. The stake represents ﹤0.01% of the portfolio and ranks #1291 among its holdings. This is a return to the name: Nomura Asset Management previously reported a position in IONS as recently as Q2 2021.

Nomura Asset Management first reported a position in IONS in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.67M in Q1 2015. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Nomura Asset Management held 270 shares of Ionis Pharmaceuticals worth $21.4K as of Q2 2026.
  • Ionis Pharmaceuticals was a new Nomura Asset Management position in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Nomura Asset Management's portfolio in Q2 2026, its #1291 holding.
  • Nomura Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
  • Nomura Asset Management's Ionis Pharmaceuticals position peaked at $1.67M in Q1 2015.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.